MeiraGTx (MGTX)
NASDAQ: MGTX
· Real-Time Price · USD
6.66
0.03 (0.45%)
At close: Jun 16, 2025, 3:59 PM
6.63
-0.38%
Pre-market: Jun 17, 2025, 08:51 AM EDT
0.45% (1D)
| Bid | 5.95 |
| Market Cap | 534.83M |
| Revenue (ttm) | 32.58M |
| Net Income (ttm) | -167.33M |
| EPS (ttm) | -2.31 |
| PE Ratio (ttm) | -2.88 |
| Forward PE | 60.32 |
| Analyst | Buy |
| Ask | 6.85 |
| Volume | 200,397 |
| Avg. Volume (20D) | 594,207 |
| Open | 6.60 |
| Previous Close | 6.63 |
| Day's Range | 6.53 - 6.75 |
| 52-Week Range | 3.85 - 8.75 |
| Beta | 1.18 |
About MGTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MGTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MGTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-0.91%
MGTX stock has given up its prior gain. MeiraGTx H...
Unlock content with
Pro Subscription
1 month ago
-0.91%
MeiraGTx Holdings shares are trading higher after the company announced it was granted an FDA regenerative medicine advanced therapy designation for its AAV-GAD treatment of parkinson's disease.
